Kevin Baker
2016
In 2016, Kevin Baker earned a total compensation of $5.3M as Senior Vice President, Product Development at Five Prime Therapeutics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $142,600 |
| Option Awards | $1,762,440 |
| Salary | $309,167 |
| Stock Awards | $2,992,575 |
| Other | $6,000 |
| Total | $5,312,782 |
Baker received $3M in stock awards, accounting for 56% of the total pay in 2016.
Baker also received $100K in bonus, $142.6K in non-equity incentive plan, $1.8M in option awards, $309.2K in salary and $6K in other compensation.
Rankings
In 2016, Kevin Baker's compensation ranked 1,475th out of 14,075 executives tracked by ExecPay. In other words, Baker earned more than 89.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,475 out of 14,075 | 90th |
Division Manufacturing | 504 out of 5,489 | 91st |
Major group Chemicals And Allied Products | 140 out of 1,895 | 93rd |
Industry group Drugs | 96 out of 1,538 | 94th |
Industry Pharmaceutical Preparations | 77 out of 1,176 | 94th |
Source: SEC filing on March 31, 2017.
Baker's colleagues
We found five more compensation records of executives who worked with Kevin Baker at Five Prime Therapeutics in 2016.
2016
Lewis Williams
Five Prime Therapeutics
Chief Executive Officer
2016
Aron Knickerbocker
Five Prime Therapeutics
Chief Operating Officer
2016
Robert Sikorski
Five Prime Therapeutics
Chief Medical Officer
2016
Francis Sarena
Five Prime Therapeutics
Secretary
2016
Marc Belsky
Five Prime Therapeutics